These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 17592745)
1. Doubly radiolabeled liposomes for pretargeted radioimmunotherapy. Mougin-Degraef M; Bourdeau C; Jestin E; Saï-Maurel C; Bourgeois M; Saëc PR; Thédrez P; Gestin JF; Barbet J; Faivre-Chauvet A Int J Pharm; 2007 Nov; 344(1-2):110-7. PubMed ID: 17592745 [TBL] [Abstract][Full Text] [Related]
2. Radiolabeling and targeting of lipidic nanocapsules for applications in radioimmunotherapy. Jestin E; Mougin-Degraef M; Faivre-Chauvet A; Remaud-Le Saëc P; Hindre F; Benoit JP; Chatal JF; Barbet J; Gestin JF Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):51-60. PubMed ID: 17372573 [TBL] [Abstract][Full Text] [Related]
3. Radiolabeling of lipid-based nanoparticles for diagnostics and therapeutic applications: a comparison using different radiometals. Helbok A; Decristoforo C; Dobrozemsky G; Rangger C; Diederen E; Stark B; Prassl R; von Guggenberg E J Liposome Res; 2010 Sep; 20(3):219-27. PubMed ID: 19863193 [TBL] [Abstract][Full Text] [Related]
4. 186Re-liposome labeling using 186Re-SNS/S complexes: in vitro stability, imaging, and biodistribution in rats. Bao A; Goins B; Klipper R; Negrete G; Phillips WT J Nucl Med; 2003 Dec; 44(12):1992-9. PubMed ID: 14660726 [TBL] [Abstract][Full Text] [Related]
5. Biodistribution and pharmacokinetics of 111In-DTPA-labelled pegylated liposomes in a human tumour xenograft model: implications for novel targeting strategies. Harrington KJ; Rowlinson-Busza G; Syrigos KN; Uster PS; Abra RM; Stewart JS Br J Cancer; 2000 Jul; 83(2):232-8. PubMed ID: 10901376 [TBL] [Abstract][Full Text] [Related]
6. Application of oligo-(14-amino-3,6,9,12-tetraoxatetradecanoic acid) lipid conjugates as steric barrier molecules in liposomal formulations. Ansell SM; Kojic LD; Hankins JS; Sekirov L; Boey A; Lee DK; Bennett AR; Klimuk SK; Harasym TO; Dos Santos N; Semple SC Bioconjug Chem; 1999; 10(4):653-66. PubMed ID: 10411464 [TBL] [Abstract][Full Text] [Related]
7. Influence of pegylation and hapten location at the surface of radiolabelled liposomes on tumour immunotargeting using bispecific antibody. Rauscher A; Frindel M; Maurel C; Maillasson M; Le Saëc P; Rajerison H; Gestin JF; Barbet J; Faivre-Chauvet A; Mougin-Degraef M Nucl Med Biol; 2014 May; 41 Suppl():e66-74. PubMed ID: 24485990 [TBL] [Abstract][Full Text] [Related]
9. Long-circulating gadolinium-encapsulated liposomes for potential application in tumor neutron capture therapy. Le UM; Cui Z Int J Pharm; 2006 Apr; 312(1-2):105-12. PubMed ID: 16457973 [TBL] [Abstract][Full Text] [Related]
10. A simple and efficient method for radiolabeling of preformed liposomes. Suresh M; Cao Y J Pharm Pharm Sci; 1998; 1(1):31-7. PubMed ID: 10942970 [TBL] [Abstract][Full Text] [Related]
11. The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats. Dadashzadeh S; Vali AM; Rezaie M Int J Pharm; 2008 Apr; 353(1-2):251-9. PubMed ID: 18191511 [TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of a DOTA-lysine-biotin conjugate as an effector molecule for pretargeted radionuclide therapy. Hainsworth J; Harrison P; Mather SJ Bioconjug Chem; 2005; 16(6):1468-74. PubMed ID: 16287243 [TBL] [Abstract][Full Text] [Related]
13. Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes. Dams ET; Laverman P; Oyen WJ; Storm G; Scherphof GL; van Der Meer JW; Corstens FH; Boerman OC J Pharmacol Exp Ther; 2000 Mar; 292(3):1071-9. PubMed ID: 10688625 [TBL] [Abstract][Full Text] [Related]
14. Radiolabeled liposomes as metabolic and scanning tracers in mice. II. In-111 oxine compared with Tc-99m DTPA, entrapped in multilamellar lipid vesicles. Espinola LG; Beaucaire J; Gottschalk A; Caride VJ J Nucl Med; 1979 May; 20(5):434-40. PubMed ID: 120420 [TBL] [Abstract][Full Text] [Related]
15. Pegylated liposomes have potential as vehicles for intratumoral and subcutaneous drug delivery. Harrington KJ; Rowlinson-Busza G; Syrigos KN; Uster PS; Vile RG; Stewart JS Clin Cancer Res; 2000 Jun; 6(6):2528-37. PubMed ID: 10873109 [TBL] [Abstract][Full Text] [Related]
16. Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model. Chow TH; Lin YY; Hwang JJ; Wang HE; Tseng YL; Wang SJ; Liu RS; Lin WJ; Yang CS; Ting G Anticancer Res; 2009 Jun; 29(6):2111-20. PubMed ID: 19528471 [TBL] [Abstract][Full Text] [Related]
17. Sterically stabilized superparamagnetic liposomes for MR imaging and cancer therapy: pharmacokinetics and biodistribution. Plassat V; Martina MS; Barratt G; Ménager C; Lesieur S Int J Pharm; 2007 Nov; 344(1-2):118-27. PubMed ID: 17583452 [TBL] [Abstract][Full Text] [Related]
18. Radioiodination of glycoprotein-conjugated liposomes by using the Bolton-Hunter reagent and biodistribution in tumor-bearing mice. Shimura N; Sogawa Y; Kawakita Y; Ikekita M; Yamazaki N; Kojima S Nucl Med Biol; 2002 May; 29(4):491-6. PubMed ID: 12031885 [TBL] [Abstract][Full Text] [Related]
19. Formulation, characterization and tissue distribution of a novel pH-sensitive long-circulating liposome-based theranostic suitable for molecular imaging and drug delivery. Duan Y; Wei L; Petryk J; Ruddy TD Int J Nanomedicine; 2016; 11():5697-5708. PubMed ID: 27843312 [TBL] [Abstract][Full Text] [Related]